RNA-Seq Market
RNA-Seq Market Scope: Industry Analysis, Market
Size, Growth, Trends Till 2031
Request Sample Report
RNA-Seq Market Size and Growth
The RNA-Seq market is experiencing significant growth, driven by advancements in sequencing technologies and increasing demand for genomics research. As of 2023, the market is valued at approximately $1.5 billion, with a projected CAGR of around 10% over the next five years, reflecting expanding applications in personalized medicine and diagnostics.
Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Thermo Fisher Scientific
◍ Illumina
◍ BGI
◍ PacBio
◍ Genewiz
◍ Macrogen
◍ LabCorp
◍ Roche
◍ Qiagen
◍ Eurofins
◍ Novo Gene
◍ Berry Genomics
The RNA-Seq market features key players like Thermo Fisher Scientific, Illumina, and Roche, among others. These companies provide innovative sequencing technologies, services, and reagents, enhancing research capabilities and accelerating breakthroughs in genomics. Their contributions drive market growth through improved efficiency and applications in diagnostics and personalized medicine.
- Thermo Fisher: $39 billion (2022)
- Illumina: $4.5 billion (2021)
- Roche: $68 billion (2022)
Request Sample Report
Market Segmentation
By Application
◍ Research Institutes
◍ Hospitals & Clinics
◍ Biotechnology Company
◍ Others
By Product
◍ sRNA-Seq
◍ targeted RNA-Seq ◍ long-read RNA-Seq
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
